A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated ...

A network meta-analysis backed weight-loss benefits with several GLP-1 receptor agonists, with less certainty for ...

Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...

Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid ...

A study by AIG Hospitals, Hyderabad, found Endoscopic Sleeve Gastroplasty (ESG) resulted in greater 6-month weight loss ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a ...

In this real-world study of patients with type 2 diabetes, treatment with semaglutide resulted in greater reductions in body weight and hemoglobin A1c than dulaglutide. Objective: To compare the ...

Taking semaglutide while breastfeeding isn’t currently advised. More research is needed to know if it’s safe. If you’re taking semaglutide for type 2 diabetes, your healthcare provider can let you ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control and ...